Dr. Reddy’s, Adani Ports, M&M Boost Market with Strong July Performance

Dr. Reddy’s Laboratories, Adani Ports and Special Economic Zone, and Mahindra & Mahindra each reported significant operational and market advancements in July 2026. These key players propelled market activity with strong performance metrics across sectors.

Dr. Reddy’s Secures USFDA Nod

Shares of Dr. Reddy’s Laboratories advanced following the United States Food and Drug Administration (USFDA) approval for its rituximab biosimilar. This strategic approval is poised to enhance the company’s global biosimilars portfolio.

• Dr. Reddy’s shares rose by 1.37%.
• The stock reached Rs. 1163.35.
• The approval strengthens its biosimilars business in the United States.

Adani Ports Reports Robust Cargo Expansion

Adani Ports and Special Economic Zone (APSEZ) demonstrated robust operational performance, handling substantial cargo volumes in July 2026. Growth was consistent across all cargo categories, reinforcing its market position.

• Cargo volume in July 2026: 46.3 MMT.
• This represents a 15% year-on-year growth.
• Dry cargo specifically surged 21% year-on-year.
• Year-to-date July 2026 cargo handling reached 184.4 MMT.
• Year-to-date growth stood at 15% year-on-year, driven by containers and dry cargo.

Mahindra & Mahindra’s Strong Auto Sales

In the automotive sector, Mahindra & Mahindra (M&M) posted a significant increase in overall auto sales for July 2026. The company’s export figures also demonstrated exceptional growth during the same period.

• Overall auto sales in July 2026 rose by 26%.
• Exports surged by 47% to 4,070 units in July 2026.
• This compares to 2,774 units exported in July last year.
• M&M shares edged up by 0.31%.
• The stock closed at Rs. 3406.90.

These individual corporate achievements highlight strong sectoral momentum, with key Indian companies delivering significant growth in their respective markets during July 2026.